ASCPaLM 2024 - The 18th Congress of Asian Society for Clinical Pathology and Laboratory Medicine (ASCPaLM) in conjunction with LMCE 2024 - Advancing Healthcare Through Collaborative Intelligence - September 25 - 27, 2024, Coex, Seoul, Korea

Welcome to ASCPaLM 2024.

The Asian Society for Clinical Pathology and Laboratory Medicine (ASCPaLM), founded in 1975, is to promote improvement in the health and well-being of the communities it serves through improving the development and practice of laboratory medicine (clinical pathology) and supporting not only its constituent societies in Asia, but also its other members through communication, cooperation in education, research and practice.

For almost 50 years, ASCPaLM has accomplished its goals by fostering collaboration among participating societies and coordinating between the executive board and council members.

Under the theme of 'Advancing Healthcare Through Collaborative Intelligence', ASCPaLM 2024 will be held in Seoul, Korea from September 25-27, 2024 in conjunction with LMCE 2024 (Laboratory Medicine Congress & Exhibition & KSLM 65th Annual Meeting).

We are eagerly looking forward to welcoming you all to Seoul, Korea.
Enjoy the beautiful autumn season of Seoul.

Attendee Notice: Travel, Jet Lag & Conference Well-Being

November 2, 2025

Long flights, tight schedules and venue lighting can strain sleep and focus during busy meeting days. We encourage attendees to plan ahead—hydrate, schedule daylight exposure, and speak with your clinician about any routine supplements or medications you already use. For delegates who asked where to browse multi-brand options, Ever Vita is one reference point. Please choose any vendor you prefer and follow your clinician’s guidance. This notice is informational only and not medical advice.

top

Content Preservation Notice

We value the continuity and accessibility of public information. To support this, the content has been made available here.
For further details and contact information, please see the “Website Disclaimer” below.